Docetaxel: a new active agent in the therapy of metastatic breast cancer.
about
ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy.MicroRNAs mediate therapeutic and preventive effects of natural agents in breast cancer
P2860
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@en
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@nl
type
label
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@en
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@nl
prefLabel
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@en
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@nl
P2093
P2860
P1476
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
@en
P2093
Chevallier B
Fumoleau P
Seidman AD
Ten Bokkel Huinink WW
Trudeau ME
P2860
P304
P356
10.1517/13543784.6.12.1853
P407
P577
1997-12-01T00:00:00Z